journal article·2021-11-24

Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific Chemotherapy

Lin Huang, Jie Feng, Wenpei Fan, Wei Tang, Xiaoxiang Rong, Wangjun Liao, Zhenni Wei, Yikai Xu, Aiguo Wu, Xiaoyuan Chen, Zheyu Shen

Nano Letters· Volume 21· Issue 22
Publisher page

Abstract

Hollow mesoporous organosilica nanoparticles (HMONs) are widely considered as a promising drug nanocarrier, but the loaded drugs can easily leak from HMONs, resulting in the considerably decreased drug loading capacity and increased biosafety risk. This study reports the smart use of core/shell Fe3O4/Gd2O3 (FG) hybrid nanoparticles as a gatekeeper to block the pores of HMONs, which can yield an unreported large loading content (up to 20.4%) of DOX. The conjugation of RGD dimer (R2) onto the DOX-loaded HMON with FG capping (D@HMON@FG@R2) allowed for active tumor-targeted delivery. The aggregated FG in D@HMON@FG@R2 could darken the normal tissue surrounding the tumor due to the high r2 value (253.7 mM−1 s−1) and high r2/r1 ratio (19.13), and the intratumorally released FG as a result of reducibility-triggered HMON degradation could brighten the tumor because of the high r1 value (20.1 mM−1 s−1) and low r2/r1 ratio (7.01), which contributed to high contrast magnetic resonance imaging (MRI) for guiding highly efficient tumor-specific DOX release and chemotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Metal-Organic Frameworks: Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Medical Imaging Center, Nanfang Hospital, School of Biomedical Engineering, Southern Medical University, 1023 Sha-Tai South Road, Guangzhou, Guangdong 510515, China

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing, 210009, China

Departments of Pharmacy and Diagnostic Radiology, Faculty of Science and Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117559, Singapore

Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

Cixi Institute of Biomedical Engineering, CAS Key Laboratory of Magnetic Materials and Devices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, 1219 Zhong-guan West Road, Ning-bo, Zhe-jiang 315201, China

Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore 119074, Singapore

Funding

National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Natural Science Foundation of Zhejiang Province · Guangzhou Key Research and Development Program of China

References (38)

Show source-provided references
1. 10.1021/acsnano.9b0873710.1021/acsnano.9b08737 ↗
2. 10.1021/acsnano.9b0110010.1021/acsnano.9b01100 ↗
3. 10.1038/nnano.2007.10810.1038/nnano.2007.108 ↗
4. 10.1038/nmat232910.1038/nmat2329 ↗
5. 10.1038/s41467-019-11082-310.1038/s41467-019-11082-3 ↗
6. 10.1002/anie.20200146910.1002/anie.202001469 ↗
7. 10.1038/s41467-018-07250-610.1038/s41467-018-07250-6 ↗
8. 10.1038/s41467-018-06730-z10.1038/s41467-018-06730-z ↗
9. 10.1002/advs.20190146210.1002/advs.201901462 ↗
10. 10.1039/C9BM01164A10.1039/C9BM01164A ↗
11. 10.1002/advs.20190195410.1002/advs.201901954 ↗
12. 10.1002/anie.20171299610.1002/anie.201712996 ↗
13. 10.1002/ange.20201565910.1002/ange.202015659 ↗
14. 10.1016/j.biomaterials.2020.12019110.1016/j.biomaterials.2020.120191 ↗
15. 10.1002/adhm.20190158210.1002/adhm.201901582 ↗
16. 10.1002/advs.20180200110.1002/advs.201802001 ↗
17. 10.1021/acsnano.8b0099910.1021/acsnano.8b00999 ↗
18. 10.1002/adma.20170761210.1002/adma.201707612 ↗
19. 10.1038/s41467-020-20860-310.1038/s41467-020-20860-3 ↗
20. 10.1038/s41467-019-09158-110.1038/s41467-019-09158-1 ↗
21. 10.1016/j.biomaterials.2017.02.01810.1016/j.biomaterials.2017.02.018 ↗
22. 10.1021/jacs.9b0608610.1021/jacs.9b06086 ↗
23. 10.1002/adfm.20180014510.1002/adfm.201800145 ↗
24. 10.1021/acsami.8b2190610.1021/acsami.8b21906 ↗
25. 10.1016/j.cej.2020.12425310.1016/j.cej.2020.124253 ↗
26. 10.1002/adma.20200438510.1002/adma.202004385 ↗
27. 10.1002/adfm.20191030410.1002/adfm.201910304 ↗
28. 10.1016/j.jconrel.2018.04.03210.1016/j.jconrel.2018.04.032 ↗
29. 10.1021/acsnano.7b0492410.1021/acsnano.7b04924 ↗
30. 10.1039/c3tb20648c10.1039/c3tb20648c ↗
31. 10.1021/acs.biomac.9b0092510.1021/acs.biomac.9b00925 ↗
32. 10.1016/j.actbio.2015.05.02810.1016/j.actbio.2015.05.028 ↗
33. 10.7150/thno.1989810.7150/thno.19898 ↗
34. 10.2116/analsci.33.27510.2116/analsci.33.275 ↗
35. 10.1002/cyto.a.2231210.1002/cyto.a.22312 ↗
36. 10.1002/adfm.20150498010.1002/adfm.201504980 ↗
37. 10.1021/acsnano.9b0857010.1021/acsnano.9b08570 ↗
38. 10.1002/anie.20200938010.1002/anie.202009380 ↗